Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Toxicity: Dose-Dependent Reactions

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...

Drug toxicity: Drug–Drug Interaction

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...

Phase II Reactions: Acetylation Reactions

Phase II Reactions: Acetylation Reactions

Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...

Pharmaceutical Poisoning: Treatment Strategies

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...

Nociception

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain. Thus, pain helps the...

Analgesia and Pain Management

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Passive transfer of allergic encephalomyelitis in rats: a tool for drug mechanism studies and detecting late-acting immunosuppressants.

Inflammopharmacology·2019

Same author

Preface. Novel Natural Products: Therapeutic Effects in Pain Arthritis and Gastro-intestinal Diseases.

Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques·2015

Same author

Synthesis and anti-inflammatory properties of some aromatic and heterocyclic aromatic curcuminoids.

Bioorganic chemistry·2011

Same author

Over the counter (OTC) oral remedies for arthritis and rheumatism: how effective are they?

Inflammopharmacology·2008

Same author

Therapeutic gold. Is it due for a come-back?

Inflammopharmacology·2008

Same author

Aurocyanide, dicyano-aurate (I), a pharmacologically active metabolite of medicinal gold complexes.

Inflammopharmacology·2008

Search research articles

Related Experiment Videos

Paracetamol (acetaminophen): a blessing or a hidden curse?

M W Whitehouse¹, D E Butters

¹School of Biomolecular Sciences and School of Medicine, Griffith University, Nathan, QLD, 4111, Australia, whitehousemd@spin.net.au.

Inflammopharmacology

|September 28, 2013

Summary

Paracetamol, an arthritis pain reliever, can offer more benefits and fewer side effects. Its effects depend on individual health factors like disease and nutrition.

Related Experiment Videos

Area of Science:

Pharmacology
Pain Management
Inflammation Research

Background:

Paracetamol is a widely used analgesic for chronic arthritis pain.
A recent review covered the established science and facts of paracetamol.
This commentary explores the metapharmacology of paracetamol.

Purpose of the Study:

To discuss how to maximize paracetamol benefits.
To explore minimizing adverse reactions to paracetamol.
To examine paracetamol's role in non-transient inflammation.

Main Methods:

Literature review and commentary.
Exploration of metapharmacological principles.
Analysis of influencing factors on drug response.

Main Results:

Paracetamol's efficacy and safety are influenced by various physiological and environmental factors.
Individual patient circumstances (e.g., disease state, nutritional status, fasting) can alter paracetamol's effects.
Understanding these factors is key to optimizing therapeutic outcomes.

Conclusions:

Paracetamol can act as both a beneficial drug and a potential toxin.
Tailoring paracetamol use based on patient-specific conditions can enhance its therapeutic index.
Further research into metapharmacology can improve analgesic strategies.